GB1001949A - Penetrating agents - Google Patents
Penetrating agentsInfo
- Publication number
- GB1001949A GB1001949A GB2787562A GB2787562A GB1001949A GB 1001949 A GB1001949 A GB 1001949A GB 2787562 A GB2787562 A GB 2787562A GB 2787562 A GB2787562 A GB 2787562A GB 1001949 A GB1001949 A GB 1001949A
- Authority
- GB
- United Kingdom
- Prior art keywords
- carbon atoms
- cycloaliphatic
- aliphatic
- penetration
- aid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A61K8/315—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
An ointment, liniment, lotion or like preparation for topical application, comprises an active agent which is to penetrate the epidermis, and, as an aid for assisting penetration of aid active agent into the epidermis, a monovalent saturated or unsaturated aliphatic, cycloaliphatic or aromatic alcohol having from 4 to 12 carbon atoms; an aliphatic, cycloaliphatic or aromatic hydrocarbon having from 5 to 12 carbon atoms; a terpene having from 9 to 15 carbon atoms; an aliphatic, cycloaliphatic or aromatic aldehyde, ketone or ester having from 4 to 10 carbon atoms; an essential oil or a substance containing an essential oil; a halogenated or nitrated aliphatic, cycloaliphatic or aromatic hydrocarbon having from 2 to 8 carbon atoms; or a mixture of two or more of such penetration aids, and any inert carrier necessary for forming said preparation, the carrier being such or being present in an amount such as not to prevent penetration by said penetration aid. Examples relate to lotions or ointments containing (a) malachite green, cyclohexane and ethyl glycol; (b) rhodamine B, cyclohexane and ethyl glycol; (c) tetracycline, n-undecane and and ethylene glycol; (d) as in (c) plus silica; (e) as in (c) using n-docosane, stearyl alcohol or cetyl alcohol in place of ethylene glycol; (f) tetracycline, n-undecone, ethylene glycol and cetyl alcohol. Numerous examples of penetrating agents are given. The preparations may be cosmetics.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEM49750A DE1227616B (en) | 1961-07-20 | 1961-07-20 | Penetration agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1001949A true GB1001949A (en) | 1965-08-18 |
Family
ID=7306610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2787562A Expired GB1001949A (en) | 1961-07-20 | 1962-07-19 | Penetrating agents |
Country Status (6)
Country | Link |
---|---|
AT (2) | AT258471B (en) |
BR (1) | BR6241165D0 (en) |
DE (1) | DE1227616B (en) |
FR (1) | FR1329357A (en) |
GB (1) | GB1001949A (en) |
NL (1) | NL281225A (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2308354A1 (en) * | 1975-04-22 | 1976-11-19 | Bus Louise | Cosmetic lotion for the treatment of acne - contg. benzaldehyde and emollients such as benzoin |
FR2369867A1 (en) * | 1976-11-08 | 1978-06-02 | Manetti & Roberts Italo Brit | ACTIVATOR FOR COSMETIC COMPOSITIONS AND COSMETIC COMPOSITIONS CONTAINING IT |
FR2399834A2 (en) * | 1977-08-09 | 1979-03-09 | Bus Louise | Skin lotion for treating acne - contains benzaldehyde, softening agent, sodium alginate and tri:ethanolamine |
FR2520233A1 (en) * | 1982-01-28 | 1983-07-29 | Oreal | COMPOSITION OF ANTHRALIN OR ONE OF ITS DERIVATIVES IN AN AROMATIC ESTER AND ITS USE IN THE TREATMENT OF SKIN DISEASES |
EP0091964A1 (en) * | 1981-09-28 | 1983-10-26 | Nitto Denko Corporation | Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent |
EP0116401A2 (en) * | 1983-01-10 | 1984-08-22 | Robert Young & Company Limited | Endoparasiticidal compositions |
EP0136033A2 (en) * | 1983-08-22 | 1985-04-03 | Ici Australia Limited | Pour-on formulation for the control of parasites |
FR2558729A1 (en) * | 1984-02-01 | 1985-08-02 | Nitto Electric Ind Co | COMPOSITION FOR PERCUTANEOUS ADMINISTRATION OF METOCLOPRAMIDE |
FR2566661A1 (en) * | 1984-07-02 | 1986-01-03 | Gendler El | Method for dissolving griseofulvin for the purpose of preparing a solution of this substance, which is chemically stable and possesses biological activity, for local applications. |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
US4865848A (en) * | 1987-02-26 | 1989-09-12 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4885154A (en) * | 1988-03-01 | 1989-12-05 | Alza Corporation | Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
EP0380047A2 (en) * | 1989-01-23 | 1990-08-01 | Freund Industrial Co., Ltd. | A percutaneous or trans-mucosal absorption enhancer and a percutaneous or trans-mucosal medicine |
WO1993007874A1 (en) * | 1991-10-26 | 1993-04-29 | Ian Flockhart | Medicament composition for topical application |
WO1993007901A1 (en) * | 1991-10-26 | 1993-04-29 | Ian Flockhart | Composition for topical application |
US5411740A (en) * | 1992-05-13 | 1995-05-02 | Alza Corporation | Transdermal administration of oxybutynin |
WO1995020403A1 (en) * | 1994-01-31 | 1995-08-03 | The Procter & Gamble Company | Aqueous topical compositions |
US5900250A (en) | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
US6426208B1 (en) | 1999-11-12 | 2002-07-30 | Harbor-Ucla Research And Education Institute | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
US6569661B1 (en) | 1999-11-12 | 2003-05-27 | Biomarin Pharmaceutical Inc. | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
US6585971B1 (en) | 1999-11-12 | 2003-07-01 | Harbor-Ucla Research And Education Institute | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
EP1454624A1 (en) * | 2001-11-23 | 2004-09-08 | Wei Wang | Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
WO2004080443A1 (en) | 2003-03-14 | 2004-09-23 | Epistem Limited | Treatment and/or prevention of non-viral epithelial damage |
WO2011027128A1 (en) | 2009-09-03 | 2011-03-10 | The University Of Manchester | Use of non-digestible oligosaccharides |
EP2327414A1 (en) | 2002-11-07 | 2011-06-01 | BioMarin Pharmaceutical Inc. | Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4005032A (en) * | 1974-09-25 | 1977-01-25 | Xerox Corporation | Liquid crystalline composition having mixed cholesteric-nematic properties |
JPS58189115A (en) * | 1982-04-30 | 1983-11-04 | Kowa Co | Drug for external use |
JPS5948413A (en) * | 1982-09-14 | 1984-03-19 | Grelan Pharmaceut Co Ltd | Anti-inflammatory and analgesic agent for external use containing clidanac |
JPS6013720A (en) * | 1983-07-01 | 1985-01-24 | Nitto Electric Ind Co Ltd | Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator |
DE102004031210A1 (en) * | 2004-06-28 | 2006-02-09 | Trommsdorff Gmbh & Co. Kg | MLV cosmetic |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE870323C (en) * | 1948-10-02 | 1953-03-12 | Johann Schmid | Process for the preparation of a liniment |
DE801283C (en) * | 1948-10-02 | 1950-12-28 | Johann Schmid | Process for the preparation of a liniment |
-
0
- NL NL281225D patent/NL281225A/xx unknown
-
1961
- 1961-07-20 DE DEM49750A patent/DE1227616B/en active Pending
-
1962
- 1962-07-17 AT AT578162A patent/AT258471B/en active
- 1962-07-17 AT AT92864A patent/AT249268B/en active
- 1962-07-19 GB GB2787562A patent/GB1001949A/en not_active Expired
- 1962-07-19 BR BR14116562A patent/BR6241165D0/en unknown
- 1962-07-20 FR FR904627A patent/FR1329357A/en not_active Expired
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2308354A1 (en) * | 1975-04-22 | 1976-11-19 | Bus Louise | Cosmetic lotion for the treatment of acne - contg. benzaldehyde and emollients such as benzoin |
FR2369867A1 (en) * | 1976-11-08 | 1978-06-02 | Manetti & Roberts Italo Brit | ACTIVATOR FOR COSMETIC COMPOSITIONS AND COSMETIC COMPOSITIONS CONTAINING IT |
FR2399834A2 (en) * | 1977-08-09 | 1979-03-09 | Bus Louise | Skin lotion for treating acne - contains benzaldehyde, softening agent, sodium alginate and tri:ethanolamine |
EP0091964A1 (en) * | 1981-09-28 | 1983-10-26 | Nitto Denko Corporation | Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent |
EP0091964A4 (en) * | 1981-09-28 | 1985-07-01 | Nitto Electric Ind Co | Base composition for preparing medicine for external application, medicinal composition for external application, and method for accelerating percutaneous absorption of medicinal agent. |
FR2520233A1 (en) * | 1982-01-28 | 1983-07-29 | Oreal | COMPOSITION OF ANTHRALIN OR ONE OF ITS DERIVATIVES IN AN AROMATIC ESTER AND ITS USE IN THE TREATMENT OF SKIN DISEASES |
EP0116401A3 (en) * | 1983-01-10 | 1985-08-07 | Robert Young & Company Limited | Endoparasiticidal compositions |
EP0116401A2 (en) * | 1983-01-10 | 1984-08-22 | Robert Young & Company Limited | Endoparasiticidal compositions |
EP0136033A3 (en) * | 1983-08-22 | 1986-03-12 | Ici Australia Limited | Pour-on formulation for the control of parasites |
EP0136033A2 (en) * | 1983-08-22 | 1985-04-03 | Ici Australia Limited | Pour-on formulation for the control of parasites |
FR2558729A1 (en) * | 1984-02-01 | 1985-08-02 | Nitto Electric Ind Co | COMPOSITION FOR PERCUTANEOUS ADMINISTRATION OF METOCLOPRAMIDE |
FR2566661A1 (en) * | 1984-07-02 | 1986-01-03 | Gendler El | Method for dissolving griseofulvin for the purpose of preparing a solution of this substance, which is chemically stable and possesses biological activity, for local applications. |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
US4865848A (en) * | 1987-02-26 | 1989-09-12 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
US5304379A (en) * | 1988-03-01 | 1994-04-19 | Alza Corporation | Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
US4885154A (en) * | 1988-03-01 | 1989-12-05 | Alza Corporation | Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
EP0380047A2 (en) * | 1989-01-23 | 1990-08-01 | Freund Industrial Co., Ltd. | A percutaneous or trans-mucosal absorption enhancer and a percutaneous or trans-mucosal medicine |
EP0380047A3 (en) * | 1989-01-23 | 1991-07-31 | Freund Industrial Co., Ltd. | A percutaneous or trans-mucosal absorption enhancer and a percutaneous or trans-mucosal medicine |
WO1993007874A1 (en) * | 1991-10-26 | 1993-04-29 | Ian Flockhart | Medicament composition for topical application |
WO1993007901A1 (en) * | 1991-10-26 | 1993-04-29 | Ian Flockhart | Composition for topical application |
US5411740A (en) * | 1992-05-13 | 1995-05-02 | Alza Corporation | Transdermal administration of oxybutynin |
US5500222A (en) * | 1992-05-13 | 1996-03-19 | Alza Corporation | Transdermal administration of oxybutynin |
US5900250A (en) | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
WO1995020403A1 (en) * | 1994-01-31 | 1995-08-03 | The Procter & Gamble Company | Aqueous topical compositions |
US6858206B2 (en) | 1999-11-12 | 2005-02-22 | Emil D. Kakkis | Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
US6426208B1 (en) | 1999-11-12 | 2002-07-30 | Harbor-Ucla Research And Education Institute | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
US6569661B1 (en) | 1999-11-12 | 2003-05-27 | Biomarin Pharmaceutical Inc. | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
US6585971B1 (en) | 1999-11-12 | 2003-07-01 | Harbor-Ucla Research And Education Institute | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
US7041487B2 (en) | 1999-11-12 | 2006-05-09 | Kakkis Emil D | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
EP1454624A1 (en) * | 2001-11-23 | 2004-09-08 | Wei Wang | Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
EP1454624A4 (en) * | 2001-11-23 | 2006-05-31 | Wei Wang | Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
EP2327414A1 (en) | 2002-11-07 | 2011-06-01 | BioMarin Pharmaceutical Inc. | Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
WO2004080443A1 (en) | 2003-03-14 | 2004-09-23 | Epistem Limited | Treatment and/or prevention of non-viral epithelial damage |
WO2011027128A1 (en) | 2009-09-03 | 2011-03-10 | The University Of Manchester | Use of non-digestible oligosaccharides |
US10265335B2 (en) | 2009-09-03 | 2019-04-23 | Curapel (Scotland) Limited | Use of non-digestible oligosaccharides |
Also Published As
Publication number | Publication date |
---|---|
FR1329357A (en) | 1963-06-07 |
NL281225A (en) | |
DE1227616B (en) | 1966-10-27 |
BR6241165D0 (en) | 1973-06-14 |
AT249268B (en) | 1966-09-12 |
AT258471B (en) | 1967-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1001949A (en) | Penetrating agents | |
GB1514287A (en) | Derivatives of alkanediols | |
IE800406L (en) | Pharmaceutical composition | |
GB884688A (en) | Skin conditioning composition | |
ES8700049A1 (en) | Composition for reducing sebum secretion | |
GB1381698A (en) | Insect repellent | |
FR2108027A1 (en) | Extract of sea-urchin gonads - for use in cosmetic and toilet formulations | |
NL159393B (en) | PROCESS FOR PREPARING AN ANTI-INFLAMMATION MEDICINAL PRODUCT CONTAINING A 9,21-DIHALOGEN-11-OXYGENATED-17-ALPHA-HYDROXY-3,20-DIKETO-1,4-PREGNADIES OR PREGNADIANS AS AN ACTIVE INGREDIENT, AND ALREADY INCLUDED OBTAINED FORMED MEDICINAL PRODUCT AND A METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE PREPARATION OF SUCH MEDICINAL PRODUCT. | |
NL139454B (en) | PROCESS FOR THE PREPARATION OF COMPOUNDS HAVING ANTI-INFLAMMATORY ACTIVITY AND OF PREPARATIONS WITH ANTI-INFLAMMATORY ACTIVITY CONTAINING THESE COMPOUNDS AS AN ACTIVE SUBSTANCE. | |
JPS51121531A (en) | Toiletry with the depressed irritation upon skin and mucous membrane | |
GB957116A (en) | Improvements in or relating to the treatment of wool | |
NL142595B (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING TRITERPEEN SAPONINS AS AN ACTIVE SUBSTANCE. | |
GB1107072A (en) | Cosmetic depigmenting compositions | |
SAKATO et al. | STUDIES ON A PISCICIDAL CONSTITUENT OF HURA CREPITANS: I. ISOLATION AND CHARACTERIZATION OF HURATOXIN AND ITS PISCICIDAL ACTIVITY | |
GB760579A (en) | Improvements relating to percutaneous therapeutic preparations | |
JPS53101540A (en) | Skin cosmetics | |
FR2360313A1 (en) | Topical medicaments against seborrhoea and acne - contg. colostrum unsaponifiable fraction and a percutaneous | |
FR1274606A (en) | Small axial dimension turbojet notably for the lift, by reaction, of vertical take-off aerodynes | |
BE622613A (en) | Process for the preparation of primary alcohols. | |
GB974218A (en) | Topical medicaments comprising 16 epi-oestriol | |
ES306598A1 (en) | Improvements in or relating to preparations for the treatment of hair | |
GB950447A (en) | Improvements in or relating to toilet preparations for the hair | |
GB347126A (en) | Remedial preparations for application to the hair and scalp | |
GB1081375A (en) | Method of making leather or skins waterproof | |
GB560694A (en) | Improvements in insecticides |